Boryung Corporation (KRX:003850)
7,970.00
-380.00 (-4.55%)
At close: Jun 8, 2026
Boryung Revenue
Boryung had revenue of 255.35B KRW in the quarter ending March 31, 2026, with 6.15% growth. This brings the company's revenue in the last twelve months to 1.03T, up 0.80% year-over-year. In the year 2025, Boryung had annual revenue of 1.02T with 0.03% growth.
Revenue (ttm)
1.03T
Revenue Growth
+0.80%
P/S Ratio
0.68
Revenue / Employee
673.34M
Employees
1,533
Market Cap
705.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.02T | 320.69M | 0.03% |
| Dec 31, 2024 | 1.02T | 157.48B | 18.32% |
| Dec 31, 2023 | 859.63B | 99.15B | 13.04% |
| Dec 31, 2022 | 760.48B | 133.20B | 21.23% |
| Dec 31, 2021 | 627.28B | 65.41B | 11.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.08T |
| Chong Kun Dang Pharmaceutical | 1.74T |
| Dong-A Socio Holdings | 1.45T |
| DongKook Pharmaceutical | 954.16B |
| Huons Global | 845.30B |
| Dong-A ST | 830.27B |
| JW Pharmaceutical | 789.95B |
| Ildong Pharmaceutical | 572.95B |